Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026)
Bausch & Lomb (BLCO) reported Share-based Compensation of $34.0 million for Q1 2026, up 21.43% on a YoY basis from $28.0 million in Q1 2025, and down 46.88% quarter-over-quarter from $64.0 million in Q4 2025.
Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Share-based Compensation for 6 years, with the latest figure at $34.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 21.43% year-over-year to $34.0 million; the trailing twelve-month figure through Mar 2026 stood at $155.0 million (up 53.47% YoY), and the FY2025 full-year result was $149.0 million, up 61.96% from the prior year.
- Share-based Compensation for Q1 2026 stood at $34.0 million, down from $64.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $64.0 million in Q4 2025, with the low at $11.0 million in Q2 2022.
- Historically, Share-based Compensation has averaged $24.2 million across 5 years, with a median of $22.0 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation declined 26.67% — and 2025, when it soared 137.04%.
- Bausch & Lomb's Share-based Compensation stood at $17.0 million in 2022, then slipped by 5.88% to $16.0 million in 2023, then jumped by 68.75% to $27.0 million in 2024, then soared by 137.04% to $64.0 million in 2025, then slumped by 46.88% to $34.0 million in 2026.
- The last three Share-based Compensation figures came in at $34.0 million (Q1 2026), $64.0 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 209.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 58.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 23.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 26.79 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 6.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 51.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.92 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 10.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 34.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 27.00 Mn |
| Dec 31, 2024 | 27.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Dec 31, 2023 | 16.00 Mn |